By cooperating with medical and educational institutions
Posted: Sun Feb 16, 2025 4:12 am
Relying on the high-quality performance and cost advantages of independent research and development and independent manufacturing, Connosten has cooperated with top medical centers in mainland China, Hong Kong and Europe, and successfully completed clinical cases in several important specialties as planned. This has laid a solid foundation for the company's high-quality development in the future to expand into the international market and serve global medical care.
On the other hand, Connosten is also actively exploring more application scenarios and clinical cooperation opportunities around the world to accelerate the popularization of technology and services. the company ecuador telegram data has made solid progress in implementing application and skills training. At the same time, clinical feedback and the team's research and development of innovative technologies form a virtuous circle, allowing robots to be integrated with artificial intelligence to complete more precise and complex surgeries, allowing technological development to promote the popularization of smart medical care and better serve society and the public.
Professor Ou Guowei, founder and CEO of Connostom, said: " 2024 is an important milestone in the development of Connostom. I would like to thank new and old shareholders for their trust and support. This is not only a high recognition of our team's implementation of innovative results, but also a firm trust in the company's long-term high-quality development. " Building the cornerstone of China's surgical robot industry " was Connostom's original intention when it set sail in 2019.
On the other hand, Connosten is also actively exploring more application scenarios and clinical cooperation opportunities around the world to accelerate the popularization of technology and services. the company ecuador telegram data has made solid progress in implementing application and skills training. At the same time, clinical feedback and the team's research and development of innovative technologies form a virtuous circle, allowing robots to be integrated with artificial intelligence to complete more precise and complex surgeries, allowing technological development to promote the popularization of smart medical care and better serve society and the public.
Professor Ou Guowei, founder and CEO of Connostom, said: " 2024 is an important milestone in the development of Connostom. I would like to thank new and old shareholders for their trust and support. This is not only a high recognition of our team's implementation of innovative results, but also a firm trust in the company's long-term high-quality development. " Building the cornerstone of China's surgical robot industry " was Connostom's original intention when it set sail in 2019.